AstraZeneca Signs First COVID-19 Vaccine For-Profit Deals
China Slowdown Hits Tagrisso
AstraZeneca is one of the sector’s top growth stories in 2021, but controversies around its COVID-19 vaccine continue to grab headlines, and Chinese price cuts bite.
